Additionally, lactylation at K331 competes with ubiquitination at the same lysine residue, reducing ubiquitin-dependent degradation of Tau via the ubiquitin-proteasome system, thereby promoting pathological Tau accumulation and accelerating AD progression [95]. The gene discussed is MAPT; the disease is Alzheimer disease.